Flotte Terry CV - American Society of Gene & Cell Therapy

Curriculum Vitae: Terence R. Flotte81. Loiler SA, Tang Q, Clarke T, Campbell-Thompson ML, Chiodo V, Hauswirth W, Cruz P, Perret-Gentil M, Atkinson MA, Ramiya VK, Flotte TR. Localized gene expression following administrationof adeno-associated viral vectors via pancreatic ducts. Mol Ther. 2005 Sep;12(3):519-27. PubMedPMID: 15979413.82. Flotte TR. Recent developments in recombinant AAV-mediated gene therapy for lung diseases. CurrGene Ther. 2005 Jun;5(3):361-6. Review. PubMed PMID:15975013.83. Flotte TR. Adeno-associated virus-mediated gene transfer for lung diseases. Hum Gene Ther. 2005Jun;16(6):643-8. Review. PubMed PMID: 15960596.84. Chen S, Kapturczak MH, Wasserfall C, Glushakova OY, Campbell-Thompson M, Deshane JS, JosephR, Cruz PE, Hauswirth WW, Madsen KM, Croker BP, Berns KI, Atkinson MA, Flotte TR, TisherCC, Agarwal A. Interleukin 10 attenuates neointimal proliferation and inflammation in aorticallografts by a heme oxygenase-dependent pathway. Proc Natl Acad Sci U S A. 2005 May17;102(20):7251-6. Epub 2005 May 6. PubMed PMID: 15878989; PubMed CentralPMCID:PMC1090475.85. Flotte TR, Berns KI. Adeno-associated virus: a ubiquitous commensal of mammals. Hum Gene Ther.2005 Apr;16(4):401-7. Review. PubMed PMID: 15871671.86. Virella-Lowell I, Zusman B, Foust K, Loiler S, Conlon T, Song S, Chesnut KA, Ferkol T, Flotte TR.Enhancing rAAV vector expression in the lung. J Gene Med. 2005 Jul;7(7):842-50. PubMed PMID:15838934.87. Milligan ED, Sloane EM, Langer SJ, Cruz PE, Chacur M, Spataro L, Wieseler-Frank J, Hammack SE,Maier SF, Flotte TR, Forsayeth JR, Leinwand LA, Chavez R, Watkins LR. Controlling neuropathicpain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10.Mol Pain. 2005 Feb 25;1:9. PubMed PMID: 15813997; PubMed Central PMCID: PMC1079940.88. Chen S, Kapturczak M, Loiler SA, Zolotukhin S, Glushakova OY, Madsen KM, Samulski RJ,Hauswirth WW, Campbell-Thompson M, Berns KI, Flotte TR, Atkinson MA, Tisher CC, Agarwal A.Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype1 and 5 vectors. Hum Gene Ther. 2005 Feb;16(2):235-47. PubMed PMID: 15761263; PubMedCentral PMCID: PMC1364465.89. Mohiuddin I, Loiler S, Zolotukhin I, Byrne BJ, Flotte TR, Snyder RO. Herpesvirus-based infectioustitering of recombinant adeno-associated viral vectors. Mol Ther. 2005 Feb;11(2):320-6. PubMedPMID: 15668144.90. Wei F-S, Song S, Zhao G, Lu Y, Li C-W, Wei J-F, Flotte TR. Stable transduction of murine embryonicstem (ES) cells with recombinant adeno-associated virus serotype 2 (rAAV2) vectors. Preclinica2(4):262-266, 2004.91. Loiler SA and Flotte TR. Alternative Capsid Strategies for Targeting Recombinant AAV Gene Therapy.Gene Therapy and Regulation 2(2): 139-148, 2004.Page 18 of 29